logo

Cns Pharmaceuticals Inc (CNSP)



Trade CNSP now with
  Date
  Headline
7/1/2021 9:06:45 AM CNS To Execute On Corporate, Regulatory Strategies To Drive Berubicin Towards Commercialization For Treatment Of GBM
6/29/2021 8:36:32 AM CNS Pharma: FDA Grants Fast Track Designation For Berubicin For Treatment Of Recurrent Glioblastoma Multiforme
5/19/2021 8:17:37 AM CNS Pharmaceuticals Opens Enrollment For Potentially Pivotal Study Evaluating Berubicin In Treatment Of Recurrent GBM
12/23/2020 8:32:45 AM CNS Pharmaceuticals Prices $10.0 Mln Public Offering
12/17/2020 9:10:53 AM CNS Pharma Says FDA Oks IND Application For Brain Cancer Drug Candidate Berubicin; Stock Surges
11/17/2020 8:07:28 AM CNS Pharmaceuticals Submits IND Application To FDA For Berubicin
10/29/2020 8:18:14 AM CNS Pharma Says Completes Manufacturing Of Berubicin For Phase 2 Clinical Trial
10/20/2020 8:13:08 AM CNS Pharma Completes U.S. Manufacturing Of Berubicin For Phase 2 Clinical Trial
10/9/2020 8:05:04 AM CNS Pharma Begins Manufacturing Of Berubicin In Europe
9/24/2020 8:25:13 AM CNS Pharmaceuticals Selects Image Analysis Group As Image Partner For Upcoming Berubicin Clinical Trials
9/3/2020 8:18:19 AM CNS Pharma Provides Update On Progress For U.S. Manufacturing Of Berubicin
8/25/2020 8:44:10 AM CNS Provides Update On Plans For Berubicin; Anticipates Submitting IND To FDA This Year
8/25/2020 8:39:00 AM CNS Provides FDA Update on IND Filing (Press Release)